The HemOnc Pulse

The HemOnc Pulse


Latest Episodes

Amer Zeidan, MBBS, MHS, on the Evolution of AML Classification, Treatment
April 06, 2023

In this episode of The HemOnc Pulse, Amer Zeidan,

What Is the Cost-Effectiveness of Pola-R-CHP in DLBCL?
March 23, 2023

Swetha Kambhampati, MD, and Nikhil Thiruvengadam,

Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma
March 09, 2023

In the latest episode of The HemOnc Pulse, Graham

What Keeps Michael Bishop, MD, Up at Night When it Comes to CAR-T?
February 23, 2023

What is it about chimeric antigen receptor (CAR)

Laurie H. Sehn, MD, MPH, on the Game-Changing Bispecifics in Follicular Lymphoma
February 09, 2023

In the latest episode of The HemOnc Pulse, Laurie

Sanam Loghavi, MD, Tells Us Why 2022 was a Major Year for MDS
January 26, 2023

Sanam Loghavi, MD, stops by The HemOnc Pulse and

Elizabeth Brem, MD, on Which CLL Abstract From ASH 2022 Can’t Be Ignored
January 12, 2023

In the latest episode of The HemOnc Pulse, podcas

Ruben Mesa, MD, Discusses MPN Updates at ASH 2022 and the Evolution of the Disease
December 29, 2022

Ruben Mesa, MD, President and Executive Director

Drs. Hagop Kantarjian and Elias Jabbour Discuss Important AML, ALL Updates From ASH 2022
December 14, 2022

In the inaugural episode of The HemOnc Pulse, pod

...
6